日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma

ABBV-368、tilsotolimod、budigalimab 和 nab-paclitaxel 联合治疗复发/转移性头颈部鳞状细胞癌患者的 1b 期研究

Daste, Amaury; Le, Xiuning; Makkouk, Amani; Patel, Maulik; Le Tourneau, Christophe; Perets, Ruth; Popovtzer, Aron; Ochsenreither, Sebastian; Haderlein, Marlen; Oliva, Marc; Sukari, Ammar; Hong, Jaehyung; Blaney, Martha; Ramathal, Cyril; McDevitt, Michael; Rosenberg, Ari J

Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach

针对HER2靶向治疗癌症亚型的进展:一种泛肿瘤方法

Adesoye, Taiwo; Dumbrava, Ecaterina E; Raghav, Kanwal P S; Sahin, Aysegul A; Chen, Hui; Lee, Sunyoung S; Javle, Milind M; Pant, Shubham; Alhalabi, Omar; Le, Xiuning; Valero, Vicente; Pohlmann, Paula R; Meric-Bernstam, Funda

Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson

在MD安德森癌症中心早期临床试验中入组的晚期非小细胞肺癌患者的治疗反应

Lim, Jeong Uk; Lin, Heather Y; Kang, Lei; Le, Hung; Tang, Tin-Yun; Champiat, Stephane; Dumbrava, Ecaterina Elena; Le, Xiuning; Naing, Aung; Piha-Paul, Sarina A; Ahnert, Jordi Rodon; Tsimberidou, Apostolia Maria; Yap, Timothy A; Fu, Siqing; Meric-Bernstam, Funda; Hong, David S

Comparative analysis of ctDNA monitoring strategies in advanced NSCLC with MET exon 14 skipping mutations treated with ensartinib

对接受恩沙替尼治疗的伴有MET外显子14跳跃突变的晚期非小细胞肺癌患者ctDNA监测策略进行比较分析

Zhou, Mo; Zhu, Yin; Sun, Xuqi; Han, Ying; Jin, Rui; Tian, Panwen; Zhao, Jun; Jin, Yang; Guo, Zhiyuan; Zhang, Yongchang; Meng, Yiran; Liu, Fei; Li, Wen; Le, Xiuning; Shen, Haifeng; Xia, Yang

Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancer

建立PET/CT临床列线图预测原发性肺癌淋巴结转移

Han, Xiaoyu; Li, Wentao; Lin, Julie; Li, Shuoyang; Saad, Maliazurina B; Kitsel, Yuliya; Heeke, Simon; Hong, Lingzhi; Mohamed, Mohamed Qayati; Le, Xiuning; Vokes, Natalie; Godoy, Myrna Cb; Carter, Brett W; Shroff, Girish S; Eapen, George; Byers, Lauren A; Vaporciyan, Ara A; Gibbons, Don L; Heymach, John; Wu, Carol C; Zhang, Jianjun; Wu, Jia

Ginsenoside-Rh2 inhibits U251 glioma cell migration and invasion via the Gab2/Akt2 pathway

人参皂苷Rh2通过Gab2/Akt2通路抑制U251胶质瘤细胞的迁移和侵袭。

Sun, Wei; Li, Ruifang; Wang, Linjuan; Han, Wenjie; Li, Jiake; Xu, Shuangli; Sun, Xiuning

Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management

针对EGFR突变型非小细胞肺癌患者的个性化治疗:从早期到晚期疾病管理

Borgeaud, Maxime; Olivier, Timothée; Bar, Jair; Saw, Stephanie Pei Li; Parikh, Kaushal; Banna, Giuseppe Luigi; De Vito, Claudio; Feldman, Jill; Le, Xiuning; Addeo, Alfredo

Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception

对人和小鼠肺腺癌前体细胞的空间和多组学分析表明,TIM-3 是癌前阻断的潜在靶点。

Bo Zhu ,Pingjun Chen ,Muhammad Aminu ,Jian-Rong Li ,Junya Fujimoto ,Yanhua Tian ,Lingzhi Hong ,Hong Chen ,Xin Hu ,Chenyang Li ,Natalie Vokes ,Andre L Moreira ,Don L Gibbons ,Luisa M Solis Soto ,Edwin Roger Parra Cuentas ,Ou Shi ,Songhui Diao ,Jie Ye ,Frank R Rojas ,Eduardo Vilar ,Anirban Maitra ,Ken Chen ,Nicolas Navin ,Monique Nilsson ,Beibei Huang ,Simon Heeke ,Jianhua Zhang ,Cara L Haymaker ,Vamsidhar Velcheti ,Daniel H Sterman ,Veena Kochat ,William I Padron ,Ludmil B Alexandrov ,Zhubo Wei ,Xiuning Le ,Linghua Wang ,Junya Fukuoka ,J Jack Lee ,Ignacio I Wistuba ,Harvey I Pass ,Mark Davis ,Samir Hanash ,Chao Cheng ,Steven Dubinett ,Avrum Spira ,Kunal Rai ,Scott M Lippman ,P Andrew Futreal ,John V Heymach ,Alexandre Reuben ,Jia Wu ,Jianjun Zhang

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

作者更正:CTLA4阻断可消除KEAP1/STK11相关的PD-(L)1抑制剂耐药性

Skoulidis, Ferdinandos; Araujo, Haniel A; Do, Minh Truong; Qian, Yu; Sun, Xin; Cobo, Ana Galan; Le, John T; Montesion, Meagan; Palmer, Rachael; Jahchan, Nadine; Juan, Joseph M; Min, Chengyin; Yu, Yi; Pan, Xuewen; Arbour, Kathryn C; Vokes, Natalie; Schmidt, Stephanie T; Molkentine, David; Owen, Dwight H; Memmott, Regan; Patil, Pradnya D; Marmarelis, Melina E; Awad, Mark M; Murray, Joseph C; Hellyer, Jessica A; Gainor, Justin F; Dimou, Anastasios; Bestvina, Christine M; Shu, Catherine A; Riess, Jonathan W; Blakely, Collin M; Pecot, Chad V; Mezquita, Laura; Tabbó, Fabrizio; Scheffler, Matthias; Digumarthy, Subba; Mooradian, Meghan J; Sacher, Adrian G; Lau, Sally C M; Saltos, Andreas N; Rotow, Julia; Johnson, Rocio Perez; Liu, Corinne; Stewart, Tyler; Goldberg, Sarah B; Killam, Jonathan; Walther, Zenta; Schalper, Kurt; Davies, Kurtis D; Woodcock, Mark G; Anagnostou, Valsamo; Marrone, Kristen A; Forde, Patrick M; Ricciuti, Biagio; Venkatraman, Deepti; Van Allen, Eliezer M; Cummings, Amy L; Goldman, Jonathan W; Shaish, Hiram; Kier, Melanie; Katz, Sharyn; Aggarwal, Charu; Ni, Ying; Azok, Joseph T; Segal, Jeremy; Ritterhouse, Lauren; Neal, Joel W; Lacroix, Ludovic; Elamin, Yasir Y; Negrao, Marcelo V; Le, Xiuning; Lam, Vincent K; Lewis, Whitney E; Kemp, Haley N; Carter, Brett; Roth, Jack A; Swisher, Stephen; Lee, Richard; Zhou, Teng; Poteete, Alissa; Kong, Yifan; Takehara, Tomohiro; Paula, Alvaro Guimaraes; Parra Cuentas, Edwin R; Behrens, Carmen; Wistuba, Ignacio I; Zhang, Jianjun; Blumenschein, George R; Gay, Carl; Byers, Lauren A; Gibbons, Don L; Tsao, Anne; Lee, J Jack; Bivona, Trever G; Camidge, D Ross; Gray, Jhannelle E; Leighl, Natasha B; Levy, Benjamin; Brahmer, Julie R; Garassino, Marina C; Gandara, David R; Garon, Edward B; Rizvi, Naiyer A; Scagliotti, Giorgio Vittorio; Wolf, Jürgen; Planchard, David; Besse, Benjamin; Herbst, Roy S; Wakelee, Heather A; Pennell, Nathan A; Shaw, Alice T; Jänne, Pasi A; Carbone, David P; Hellmann, Matthew D; Rudin, Charles M; Albacker, Lee; Mann, Helen; Zhu, Zhou; Lai, Zhongwu; Stewart, Ross; Peters, Solange; Johnson, Melissa L; Wong, Kwok K; Huang, Alan; Winslow, Monte M; Rosen, Michael J; Winters, Ian P; Papadimitrakopoulou, Vassiliki A; Cascone, Tina; Jewsbury, Philip; Heymach, John V

A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial)

奥希替尼联合或不联合雷莫芦单抗治疗酪氨酸激酶抑制剂初治的EGFR突变转移性非小细胞肺癌的多中心开放标签随机II期研究(RAMOSE试验)

Le, Xiuning; Patel, Jyoti D; Shum, Elaine; Baik, Christina; Sanborn, Rachel E; Shu, Catherine A; Kim, Chul; Fidler, Mary Jo; Hall, Richard; Elamin, Yasir Y; Tu, Janet; Blumenschein, George; Zhang, Jianjun; Gibbons, Don; Gay, Carl; Mohindra, Nisha A; Chae, Young; Boumber, Yanis; Sabari, Joshua; Santana-Davila, Rafael; Rogosin, Shane; Herzberg, Benjamin; Creelan, Ben; Pellini, Bruna; Tanvetyanon, Tawee; Heeke, Simon; Hernandez, Mike; Gray, Jhanelle E; Saltos, Andreas; Heymach, John V